InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the complete record of transactions filed by David Glenn, 董事长兼首席执行官. Officer active across 2 companies, notably Zoetis Inc.. Aggregated, 7 disclosures have been published. Activity tracked since 23 February 2022. The latest transaction was disclosed on 6 August 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 条申报中的 7 条
David Glenn is President and Chief Executive Officer. He has 7 filings in total, and across the 7 recent filings we hold, the modal transaction nature is option exercise, with a period from 2022-02-15 to 2026-08-10. Reference amounts include EUR 313745.1594755737 at Zoetis Inc. on 2022-02-24 and EUR 26697.35845850927 at Phibro Animal Health CORP on 2026-08-06.